← Oncology Approval Tracker

FDA DECISION ·

Xeloda

capecitabine · Genentech

FDA approvalNew or expanded indicationColorectal cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adjuvant use in stage III colon cancer either alone or as part of combination chemotherapy.

LAMPGEN ANALYSIS

Why it matters

The Project Renewal decision updates the postoperative indication to include combination treatment.

What research teams should watch

Document surgical stage and identify the full regimen rather than reporting all postoperative capecitabine as monotherapy.

PRIMARY RECORDS

Sources